+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Photodynamic therapy of lung cancer with bronchial artery infusion of photofrin



Photodynamic therapy of lung cancer with bronchial artery infusion of photofrin



Diagnostic and Therapeutic Endoscopy 2(4): 203-206



Photodynamic therapy (PDT) utilizing Photofrin is proving to be effective for the treatment of early stage lung cancer. However, wider clinical applications of Photofrin as a photosensitizer for various cancers are hampered by potentially serious and prolonged skin photosensitivity. To prevent these side effects and reduce the hospitalization period, we recently gave reduced doses of Photofrin by bronchial arterial infusion. Five patients with endoscopically evaluated minimally invasive carcinoma of the lung were given 0.7 mg/kg of Photofrin by bronchial arterial infusion 48 hr before PDT. Complete remission was obtained in all 5 cases and no case showed skin photosensitivity when exposed to sunlight under careful surveillance at one week after PDT.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054983596

Download citation: RISBibTeXText

PMID: 18493405

DOI: 10.1155/DTE.2.203


Related references

A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. Journal of Clinical Oncology 11(10): 1852-1857, 1993

Bronchial artery infusion therapy for lung cancer. Cancer 24(5): 912-922, 1969

Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(10): 1369-1374, 1993

Phase II study of photodynamic therapy with photofrin II for Hilar type early lung cancer. Spinelli, P, Dal Fante, M, Marchesini, R International Congress Series; Photodynamic therapy and biomedical lasers: 614-617, 1992

Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to Photofrin-mediated photodynamic therapy. Photochemistry & Photobiology 65(1): 166-176, 1997

In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy. Journal of Photochemistry & Photobiology B Biology 49(2-3): 136-141, 1999

Bronchial artery infusion therapy for lung cancer as surgical adjuvant chemotherapy. Analysis of 170 cases in Japan. Panminerva Medica 17(9-10): 290-293, 1975

Evaluation of tumor response to radiation therapy combined with bronchial artery infusion in primary lung cancer. Nihon Ika Daigaku Zasshi 50(1): 42-51, 1983

In vitro survival of nonsmall cell lung cancer cells following combined treatment with ionizing radiation and photofrin-mediated photodynamic therapy. Photochemistry and Photobiology 85(1): 99-106, 2008

Photodynamic therapy for intractable bronchial lung cancer. Photodiagnosis and Photodynamic Therapy 10(4): 672-676, 2014

Interventional DSA in lung cancer--bronchial artery infusion. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt 2-1): 1173-1180, 1989

Effects of bronchial artery infusion therapy on lung metastasis of osteosarcoma. Gan No Rinsho. Japan Journal of Cancer Clinics 14(9): 804-811, 1968

Bronchial Artery Infusion Therapy Of Lung Neoplasms With Nitrogen Mustard. Surgery 56: 897-904, 1964

Effects of infusion of cis-platinum into the bronchial artery in lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(9): 1871-1874, 1984

Clinical evaluation of bronchial artery infusion (BAI) in lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 613-618, 1991